Fourth-quarter revenue of $912.0 millionFourth-quarter net income attributable to ChampionX of $82.8 millionFourth-quarter adjusted EBITDA of ...
The rise of counterfeit fentanyl-laced pharmaceuticals threatens public health. Innovative molecular analytical methods are ...
Trump's tariff threats prompt Mexico and Canada to bolster anti-fentanyl efforts, while China's role remains contentious.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback